Cargando…
A phenome-guided drug repositioning through a latent variable model
BACKGROUND: The phenome represents a distinct set of information in the human population. It has been explored particularly in its relationship with the genome to identify correlations for diseases. The phenome has been also explored for drug repositioning with efforts focusing on the search space f...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137076/ https://www.ncbi.nlm.nih.gov/pubmed/25103881 http://dx.doi.org/10.1186/1471-2105-15-267 |
_version_ | 1782331068105359360 |
---|---|
author | Bisgin, Halil Liu, Zhichao Fang, Hong Kelly, Reagan Xu, Xiaowei Tong, Weida |
author_facet | Bisgin, Halil Liu, Zhichao Fang, Hong Kelly, Reagan Xu, Xiaowei Tong, Weida |
author_sort | Bisgin, Halil |
collection | PubMed |
description | BACKGROUND: The phenome represents a distinct set of information in the human population. It has been explored particularly in its relationship with the genome to identify correlations for diseases. The phenome has been also explored for drug repositioning with efforts focusing on the search space for the most similar candidate drugs. For a comprehensive analysis of the phenome, we assumed that all phenotypes (indications and side effects) were inter-connected with a probabilistic distribution and this characteristic may offer an opportunity to identify new therapeutic indications for a given drug. Correspondingly, we employed Latent Dirichlet Allocation (LDA), which introduces latent variables (topics) to govern the phenome distribution. RESULTS: We developed our model on the phenome information in Side Effect Resource (SIDER). We first developed a LDA model optimized based on its recovery potential through perturbing the drug-phenotype matrix for each of the drug-indication pairs where each drug-indication relationship was switched to “unknown” one at the time and then recovered based on the remaining drug-phenotype pairs. Of the probabilistically significant pairs, 70% was successfully recovered. Next, we applied the model on the whole phenome to narrow down repositioning candidates and suggest alternative indications. We were able to retrieve approved indications of 6 drugs whose indications were not listed in SIDER. For 908 drugs that were present with their indication information, our model suggested alternative treatment options for further investigations. Several of the suggested new uses can be supported with information from the scientific literature. CONCLUSIONS: The results demonstrated that the phenome can be further analyzed by a generative model, which can discover probabilistic associations between drugs and therapeutic uses. In this regard, LDA serves as an enrichment tool to explore new uses of existing drugs by narrowing down the search space. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2105-15-267) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4137076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41370762014-08-19 A phenome-guided drug repositioning through a latent variable model Bisgin, Halil Liu, Zhichao Fang, Hong Kelly, Reagan Xu, Xiaowei Tong, Weida BMC Bioinformatics Methodology Article BACKGROUND: The phenome represents a distinct set of information in the human population. It has been explored particularly in its relationship with the genome to identify correlations for diseases. The phenome has been also explored for drug repositioning with efforts focusing on the search space for the most similar candidate drugs. For a comprehensive analysis of the phenome, we assumed that all phenotypes (indications and side effects) were inter-connected with a probabilistic distribution and this characteristic may offer an opportunity to identify new therapeutic indications for a given drug. Correspondingly, we employed Latent Dirichlet Allocation (LDA), which introduces latent variables (topics) to govern the phenome distribution. RESULTS: We developed our model on the phenome information in Side Effect Resource (SIDER). We first developed a LDA model optimized based on its recovery potential through perturbing the drug-phenotype matrix for each of the drug-indication pairs where each drug-indication relationship was switched to “unknown” one at the time and then recovered based on the remaining drug-phenotype pairs. Of the probabilistically significant pairs, 70% was successfully recovered. Next, we applied the model on the whole phenome to narrow down repositioning candidates and suggest alternative indications. We were able to retrieve approved indications of 6 drugs whose indications were not listed in SIDER. For 908 drugs that were present with their indication information, our model suggested alternative treatment options for further investigations. Several of the suggested new uses can be supported with information from the scientific literature. CONCLUSIONS: The results demonstrated that the phenome can be further analyzed by a generative model, which can discover probabilistic associations between drugs and therapeutic uses. In this regard, LDA serves as an enrichment tool to explore new uses of existing drugs by narrowing down the search space. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2105-15-267) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-08 /pmc/articles/PMC4137076/ /pubmed/25103881 http://dx.doi.org/10.1186/1471-2105-15-267 Text en © Bisgin et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Article Bisgin, Halil Liu, Zhichao Fang, Hong Kelly, Reagan Xu, Xiaowei Tong, Weida A phenome-guided drug repositioning through a latent variable model |
title | A phenome-guided drug repositioning through a latent variable model |
title_full | A phenome-guided drug repositioning through a latent variable model |
title_fullStr | A phenome-guided drug repositioning through a latent variable model |
title_full_unstemmed | A phenome-guided drug repositioning through a latent variable model |
title_short | A phenome-guided drug repositioning through a latent variable model |
title_sort | phenome-guided drug repositioning through a latent variable model |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137076/ https://www.ncbi.nlm.nih.gov/pubmed/25103881 http://dx.doi.org/10.1186/1471-2105-15-267 |
work_keys_str_mv | AT bisginhalil aphenomeguideddrugrepositioningthroughalatentvariablemodel AT liuzhichao aphenomeguideddrugrepositioningthroughalatentvariablemodel AT fanghong aphenomeguideddrugrepositioningthroughalatentvariablemodel AT kellyreagan aphenomeguideddrugrepositioningthroughalatentvariablemodel AT xuxiaowei aphenomeguideddrugrepositioningthroughalatentvariablemodel AT tongweida aphenomeguideddrugrepositioningthroughalatentvariablemodel AT bisginhalil phenomeguideddrugrepositioningthroughalatentvariablemodel AT liuzhichao phenomeguideddrugrepositioningthroughalatentvariablemodel AT fanghong phenomeguideddrugrepositioningthroughalatentvariablemodel AT kellyreagan phenomeguideddrugrepositioningthroughalatentvariablemodel AT xuxiaowei phenomeguideddrugrepositioningthroughalatentvariablemodel AT tongweida phenomeguideddrugrepositioningthroughalatentvariablemodel |